164 related articles for article (PubMed ID: 31642056)
1. Optimizing cancer care for hepatocellular carcinoma at a safety-net hospital: The value of a multidisciplinary disease management team.
Duininck G; Lopez-Aguiar AG; Lee RM; Miller L; Dariushnia S; Wu C; Alese OB; Lin JY; Wedd J; Adams A; Maithel SK; Russell MC
J Surg Oncol; 2019 Dec; 120(8):1365-1370. PubMed ID: 31642056
[TBL] [Abstract][Full Text] [Related]
2. The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Am Surg; 2020 Jul; 86(7):865-872. PubMed ID: 32721171
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a Voice Messaging System is Associated With Improved Time-to-Treatment and Overall Survival in Patients With Hepatocellular Carcinoma.
Mokdad A; Browning T; Mansour JC; Zhu H; Singal AG; Yopp AC
J Natl Compr Canc Netw; 2016 Jan; 14(1):38-46. PubMed ID: 26733553
[TBL] [Abstract][Full Text] [Related]
4. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
[TBL] [Abstract][Full Text] [Related]
5. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
Agarwal PD; Phillips P; Hillman L; Lucey MR; Lee F; Mezrich JD; Said A
J Clin Gastroenterol; 2017 Oct; 51(9):845-849. PubMed ID: 28877082
[TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study.
Turgeon MK; Lee RM; Gamboa AC; Yopp A; Ryon EL; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
HPB (Oxford); 2021 Mar; 23(3):422-433. PubMed ID: 32778389
[TBL] [Abstract][Full Text] [Related]
8. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
9. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
10. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
13. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.
Leykum LK; El-Serag HB; Cornell J; Papadopoulos KP
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):508-12. PubMed ID: 17382601
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome.
Yopp AC; Mansour JC; Beg MS; Arenas J; Trimmer C; Reddick M; Pedrosa I; Khatri G; Yakoo T; Meyer JJ; Shaw J; Marrero JA; Singal AG
Ann Surg Oncol; 2014 Apr; 21(4):1287-95. PubMed ID: 24318095
[TBL] [Abstract][Full Text] [Related]
15. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
16. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
Moon AM; Weiss NS; Beste LA; Su F; Ho SB; Jin GY; Lowy E; Berry K; Ioannou GN
Gastroenterology; 2018 Oct; 155(4):1128-1139.e6. PubMed ID: 29981779
[TBL] [Abstract][Full Text] [Related]
17. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a Hepatocellular Carcinoma Screening Program for At-risk Patients Safety-Net Hospital: A Model for National Dissemination.
Lee RM; Darby R; Medin CR; Haser GC; Mason MC; Miller LS; Staley CA; Maithel SK; Russell MC
Ann Surg; 2022 Sep; 276(3):545-553. PubMed ID: 35837969
[TBL] [Abstract][Full Text] [Related]
19. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
[TBL] [Abstract][Full Text] [Related]
20. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]